File Download
 
Links for fulltext
(May Require Subscription)
 
Supplementary

Article: International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation
  • Basic View
  • Metadata View
  • XML View
TitleInternational Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation
 
AuthorsPalumbo, A16
Sezer, O23
Kyle, R8
Miguel, JS26
Orlowski, RZ19
Moreau, P5
Niesvizky, R9
Morgan, G6
Comenzo, R21
Sonneveld, P7
Kumar, S8
Hajek, R20
Giralt, S19
Bringhen, S16
Anderson, KC23 16
Richardson, PG13
Cavo, M10
Davies, F6
Bladé, J1
Einsele, H28
Dimopoulos, MA25
Spencer, A18
Dispenzieri, A8
Reiman, T24
Shimizu, K14
Lee, JH4
Attal, M2
Boccadoro, M16
Mateos, M26
Chen, W27
Ludwig, H17
Joshua, D12
Chim, J22
Hungria, V3
Turesson, I11
Durie, BGM29
Lonial, S15
 
Issue Date2009
 
PublisherNature Publishing Group. The Journal's web site is located at http://www.nature.com/leu
 
CitationLeukemia, 2009, v. 23 n. 10, p. 1716-1730 [How to Cite?]
DOI: http://dx.doi.org/10.1038/leu.2009.122
 
AbstractIn 2005, the first guidelines were published on the management of patients with multiple myeloma (MM). An expert panel reviewed the currently available literature as the basis for a set of revised and updated consensus guidelines for the diagnosis and management of patients with MM who are not eligible for autologous stem cell transplantation. Here we present recommendations on the diagnosis, treatment of newly diagnosed non-transplant-eligible patients and the management of complications occurring during induction therapy among these patients. These guidelines will aid the physician in daily clinical practice and will ensure optimal care for patients with MM.
 
ISSN0887-6924
2012 Impact Factor: 10.164
2012 SCImago Journal Rankings: 3.379
 
DOIhttp://dx.doi.org/10.1038/leu.2009.122
 
ISI Accession Number IDWOS:000270816300005
 
ReferencesReferences in Scopus
 
DC FieldValue
dc.contributor.authorPalumbo, A
 
dc.contributor.authorSezer, O
 
dc.contributor.authorKyle, R
 
dc.contributor.authorMiguel, JS
 
dc.contributor.authorOrlowski, RZ
 
dc.contributor.authorMoreau, P
 
dc.contributor.authorNiesvizky, R
 
dc.contributor.authorMorgan, G
 
dc.contributor.authorComenzo, R
 
dc.contributor.authorSonneveld, P
 
dc.contributor.authorKumar, S
 
dc.contributor.authorHajek, R
 
dc.contributor.authorGiralt, S
 
dc.contributor.authorBringhen, S
 
dc.contributor.authorAnderson, KC
 
dc.contributor.authorRichardson, PG
 
dc.contributor.authorCavo, M
 
dc.contributor.authorDavies, F
 
dc.contributor.authorBladé, J
 
dc.contributor.authorEinsele, H
 
dc.contributor.authorDimopoulos, MA
 
dc.contributor.authorSpencer, A
 
dc.contributor.authorDispenzieri, A
 
dc.contributor.authorReiman, T
 
dc.contributor.authorShimizu, K
 
dc.contributor.authorLee, JH
 
dc.contributor.authorAttal, M
 
dc.contributor.authorBoccadoro, M
 
dc.contributor.authorMateos, M
 
dc.contributor.authorChen, W
 
dc.contributor.authorLudwig, H
 
dc.contributor.authorJoshua, D
 
dc.contributor.authorChim, J
 
dc.contributor.authorHungria, V
 
dc.contributor.authorTuresson, I
 
dc.contributor.authorDurie, BGM
 
dc.contributor.authorLonial, S
 
dc.date.accessioned2010-05-31T03:48:39Z
 
dc.date.available2010-05-31T03:48:39Z
 
dc.date.issued2009
 
dc.description.abstractIn 2005, the first guidelines were published on the management of patients with multiple myeloma (MM). An expert panel reviewed the currently available literature as the basis for a set of revised and updated consensus guidelines for the diagnosis and management of patients with MM who are not eligible for autologous stem cell transplantation. Here we present recommendations on the diagnosis, treatment of newly diagnosed non-transplant-eligible patients and the management of complications occurring during induction therapy among these patients. These guidelines will aid the physician in daily clinical practice and will ensure optimal care for patients with MM.
 
dc.description.natureLink_to_subscribed_fulltext
 
dc.identifier.citationLeukemia, 2009, v. 23 n. 10, p. 1716-1730 [How to Cite?]
DOI: http://dx.doi.org/10.1038/leu.2009.122
 
dc.identifier.citeulike4761024
 
dc.identifier.doihttp://dx.doi.org/10.1038/leu.2009.122
 
dc.identifier.epage1730
 
dc.identifier.hkuros161100
 
dc.identifier.isiWOS:000270816300005
 
dc.identifier.issn0887-6924
2012 Impact Factor: 10.164
2012 SCImago Journal Rankings: 3.379
 
dc.identifier.issue10
 
dc.identifier.openurl
 
dc.identifier.pmid19494840
 
dc.identifier.scopuseid_2-s2.0-70350094381
 
dc.identifier.spage1716
 
dc.identifier.urihttp://hdl.handle.net/10722/59372
 
dc.identifier.volume23
 
dc.languageeng
 
dc.publisherNature Publishing Group. The Journal's web site is located at http://www.nature.com/leu
 
dc.publisher.placeUnited Kingdom
 
dc.relation.ispartofLeukemia
 
dc.relation.referencesReferences in Scopus
 
dc.subject.meshAntineoplastic Agents - administration and dosage
 
dc.subject.meshHematopoietic Stem Cell Transplantation
 
dc.subject.meshMultiple Myeloma - diagnosis - therapy
 
dc.subject.meshTransplantation, Autologous
 
dc.titleInternational Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation
 
dc.typeArticle
 
<?xml encoding="utf-8" version="1.0"?>
<item><contributor.author>Palumbo, A</contributor.author>
<contributor.author>Sezer, O</contributor.author>
<contributor.author>Kyle, R</contributor.author>
<contributor.author>Miguel, JS</contributor.author>
<contributor.author>Orlowski, RZ</contributor.author>
<contributor.author>Moreau, P</contributor.author>
<contributor.author>Niesvizky, R</contributor.author>
<contributor.author>Morgan, G</contributor.author>
<contributor.author>Comenzo, R</contributor.author>
<contributor.author>Sonneveld, P</contributor.author>
<contributor.author>Kumar, S</contributor.author>
<contributor.author>Hajek, R</contributor.author>
<contributor.author>Giralt, S</contributor.author>
<contributor.author>Bringhen, S</contributor.author>
<contributor.author>Anderson, KC</contributor.author>
<contributor.author>Richardson, PG</contributor.author>
<contributor.author>Cavo, M</contributor.author>
<contributor.author>Davies, F</contributor.author>
<contributor.author>Blad&#233;, J</contributor.author>
<contributor.author>Einsele, H</contributor.author>
<contributor.author>Dimopoulos, MA</contributor.author>
<contributor.author>Spencer, A</contributor.author>
<contributor.author>Dispenzieri, A</contributor.author>
<contributor.author>Reiman, T</contributor.author>
<contributor.author>Shimizu, K</contributor.author>
<contributor.author>Lee, JH</contributor.author>
<contributor.author>Attal, M</contributor.author>
<contributor.author>Boccadoro, M</contributor.author>
<contributor.author>Mateos, M</contributor.author>
<contributor.author>Chen, W</contributor.author>
<contributor.author>Ludwig, H</contributor.author>
<contributor.author>Joshua, D</contributor.author>
<contributor.author>Chim, J</contributor.author>
<contributor.author>Hungria, V</contributor.author>
<contributor.author>Turesson, I</contributor.author>
<contributor.author>Durie, BGM</contributor.author>
<contributor.author>Lonial, S</contributor.author>
<date.accessioned>2010-05-31T03:48:39Z</date.accessioned>
<date.available>2010-05-31T03:48:39Z</date.available>
<date.issued>2009</date.issued>
<identifier.citation>Leukemia, 2009, v. 23 n. 10, p. 1716-1730</identifier.citation>
<identifier.issn>0887-6924</identifier.issn>
<identifier.uri>http://hdl.handle.net/10722/59372</identifier.uri>
<description.abstract>In 2005, the first guidelines were published on the management of patients with multiple myeloma (MM). An expert panel reviewed the currently available literature as the basis for a set of revised and updated consensus guidelines for the diagnosis and management of patients with MM who are not eligible for autologous stem cell transplantation. Here we present recommendations on the diagnosis, treatment of newly diagnosed non-transplant-eligible patients and the management of complications occurring during induction therapy among these patients. These guidelines will aid the physician in daily clinical practice and will ensure optimal care for patients with MM.</description.abstract>
<language>eng</language>
<publisher>Nature Publishing Group. The Journal&apos;s web site is located at http://www.nature.com/leu</publisher>
<relation.ispartof>Leukemia</relation.ispartof>
<subject.mesh>Antineoplastic Agents - administration and dosage</subject.mesh>
<subject.mesh>Hematopoietic Stem Cell Transplantation</subject.mesh>
<subject.mesh>Multiple Myeloma - diagnosis - therapy</subject.mesh>
<subject.mesh>Transplantation, Autologous</subject.mesh>
<title>International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation</title>
<type>Article</type>
<identifier.openurl>http://library.hku.hk:4550/resserv?sid=HKU:IR&amp;issn=0887-6924&amp;volume=&amp;spage=&amp;epage=&amp;date=2009&amp;atitle=International+Myeloma+Working+Group+guidelines+for+the+management+of+multiple+myeloma+patients+ineligible+for+standard+high-dose+chemotherapy+with+autologous+stem+cell+transplantation</identifier.openurl>
<description.nature>Link_to_subscribed_fulltext</description.nature>
<identifier.doi>10.1038/leu.2009.122</identifier.doi>
<identifier.pmid>19494840</identifier.pmid>
<identifier.scopus>eid_2-s2.0-70350094381</identifier.scopus>
<identifier.hkuros>161100</identifier.hkuros>
<relation.references>http://www.scopus.com/mlt/select.url?eid=2-s2.0-70350094381&amp;selection=ref&amp;src=s&amp;origin=recordpage</relation.references>
<identifier.volume>23</identifier.volume>
<identifier.issue>10</identifier.issue>
<identifier.spage>1716</identifier.spage>
<identifier.epage>1730</identifier.epage>
<identifier.isi>WOS:000270816300005</identifier.isi>
<publisher.place>United Kingdom</publisher.place>
<identifier.citeulike>4761024</identifier.citeulike>
</item>
Author Affiliations
  1. Hospital Clinic Barcelona
  2. Hôpital Purpan
  3. Clinica São Germano
  4. Gachon University of Medicine and Science
  5. Centre Hospitalier Universitaire de Nantes
  6. Royal Marsden Hospital, London
  7. Erasmus University Medical Center
  8. Mayo Clinic
  9. Weill Cornell Medical College
  10. Institute of Hematology and Medical Oncology Seragnoli
  11. Malmö University Hospital
  12. University of Sydney
  13. Dana-Farber Cancer Institute
  14. Nagoya City Midori General Hospital
  15. Emory University
  16. Università degli Studi di Torino
  17. First Dept. of Med./Medical Oncology
  18. Alfred Hospital
  19. University of Texas M. D. Anderson Cancer Center
  20. Fakultni Nemocnice Brno
  21. Tufts Medical Center
  22. Queen Mary Hospital Hong Kong
  23. null
  24. Cross Cancer Institute
  25. University of Athens Medical School
  26. Hospital Universitario de Salamanca
  27. Capital Medical University China
  28. null
  29. Cedars-Sinai Medical Center